» Articles » PMID: 34624136

Insights into Modifiable Risk Factors of Cholelithiasis: A Mendelian Randomization Study

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2021 Oct 8
PMID 34624136
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The risk factors of cholelithiasis have not been clearly identified, especially for total cholesterol. Here, we try to identify these causal risk factors.

Approach And Results: We obtained genetic variants associated with the exposures at the genome-wide significance (p < 5 × 10 ) level from corresponding genome-wide association studies. Summary-level statistical data for cholelithiasis were obtained from FinnGen and UK Biobank (UKB) consortia. Both univariable and multivariable Mendelian randomization (MR) analyses were conducted to identify causal risk factors of cholelithiasis. Results from FinnGen and UKB were combined using the fixed-effect model. In FinnGen, the odds of cholelithiasis increased per 1-SD increase of body mass index (BMI) (OR = 1.631, p = 2.16 × 10 ), together with body fat percentage (OR = 2.108, p = 4.56 × 10 ) and fasting insulin (OR = 2.340, p = 9.09 × 10 ). The odds of cholelithiasis would also increase with lowering of total cholesterol (OR = 0.789, p = 8.34 × 10 ) and low-density lipoprotein-cholesterol (LDL-C) (OR = 0.792, p = 2.45 × 10 ). However, LDL-C was not significant in multivariable MR. In UKB, the results of BMI, body fat percentage, total cholesterol, and LDL-C were replicated. In meta-analysis, the liability to type 2 diabetes mellitus and smoking could also increase the risk of cholelithiasis. Moreover, there were no associations with other predominant risk factors.

Conclusions: Our MR study corroborated the risk factors of cholelithiasis from previous MR studies. Furthermore, lower total cholesterol level could be an independent risk factor.

Citing Articles

Association of dietary quality indicators with gallstones in the US: NHANES 2017-2020.

Wu W, Pei Y, Wang J, Liang Q, Chen W BMC Public Health. 2025; 25(1):976.

PMID: 40075394 PMC: 11905512. DOI: 10.1186/s12889-025-21783-8.


Comprehensive causal analysis between autoimmune diseases and glioma: A Mendelian randomization study.

Deng N, Agila R, He Q, You C, Zheng S Medicine (Baltimore). 2025; 104(10):e41815.

PMID: 40068088 PMC: 11902947. DOI: 10.1097/MD.0000000000041815.


Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis.

Zhou J, Wang H, Chen C, Wang K, Xu Y Int J Clin Pharm. 2025; .

PMID: 40053301 DOI: 10.1007/s11096-025-01893-4.


Two-Sample Bidirectional Mendelian Randomization Study With Causal Association Between Metabolic Syndrome and Cerebral Aneurysm.

Li Y, Zhao K Brain Behav. 2025; 15(3):e70396.

PMID: 40038846 PMC: 11879889. DOI: 10.1002/brb3.70396.


Moderate and severe depression increase the incidence of cholelithiasis: Results from Mendelian randomization study and the NHANES 2017-March 2020.

Ma M, Xie K, Jin T, Xu F Soc Psychiatry Psychiatr Epidemiol. 2025; .

PMID: 39982470 DOI: 10.1007/s00127-025-02843-1.